---
figid: PMC9111413__ALL-9999-0-g003
figtitle: 'Non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers
  on antiviral and allergic responses: EAACI task force on eicosanoids consensus report
  in times of COVID‐19'
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Adenoviridae
- Influenza A virus
- Severe acute respiratory syndrome-related coronavirus
- Respiratory syncytial virus
- Orthomyxoviridae
- Enterovirus
- Mus musculus
- Nicotiana tabacum
- Cavia porcellus
- Arachis hypogaea
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9111413
filename: ALL-9999-0-g003.jpg
figlink: /pmc/articles/PMC9111413/figure/all15258-fig-0001/
number: F1
caption: Eicosanoid biosynthesis and signaling pathways are therapeutic targets of
  medications used in the treatment of infections, acute and chronic inflammatory
  diseases (including asthma and allergy) and pain. Glucocorticosteroids (GCs), non‐steroidal
  anti‐inflammatory drugs (NSAIDs), leukotriene receptor antagonists (LTRAs, e.g.,
  montelukast, zafirlukast, pranlukast), 5‐lipoxygenase (5‐LOX) inhibitor, zileuton,
  as well as still clinically tested, timapiprant and setitpiprant act directly on
  the synthesis of eicosanoid mediators or their signaling molecules and receptors.
  Biosynthesis of endocannabinoids (2‐AG, AEA) interfere with eicosanoids metabolic
  pathways. 2‐AG—2‐Arachidonoyl‐glycerol (endocannabinoid); AEA—arachidonyl‐ethanolamide
  (endocannabinoid); COX—cyclooxygenase; Cyt—cytochrome; EET—epoxyeicosatrienoic acid;
  GC—glucocorticoids; HETE—hydroxyeicosatetraenoic acid; HPETE—hydroperoxyeicosatetraenoic
  acid; LOX—lipoxygenase; LTE4—leukotriene; LTRA—leukotriene receptor antagonists;
  LX—lipoxin; PLA—phospholipase; PG—prostaglandin; and TX—thromboxane
papertitle: 'Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid
  pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids
  consensus report in times of COVID‐19.'
reftext: Milena Sokolowska, et al. Allergy. 2022 Feb 25 :10.1111/all.15258.
year: '2022'
doi: 10.1111/all.15258
journal_title: Allergy
journal_nlm_ta: Allergy
publisher_name: John Wiley and Sons Inc.
keywords: asthma | biologicals | COVID‐19 | LTRA | NSAID
automl_pathway: 0.9433277
figid_alias: PMC9111413__F1
figtype: Figure
redirect_from: /figures/PMC9111413__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9111413__ALL-9999-0-g003.html
  '@type': Dataset
  description: Eicosanoid biosynthesis and signaling pathways are therapeutic targets
    of medications used in the treatment of infections, acute and chronic inflammatory
    diseases (including asthma and allergy) and pain. Glucocorticosteroids (GCs),
    non‐steroidal anti‐inflammatory drugs (NSAIDs), leukotriene receptor antagonists
    (LTRAs, e.g., montelukast, zafirlukast, pranlukast), 5‐lipoxygenase (5‐LOX) inhibitor,
    zileuton, as well as still clinically tested, timapiprant and setitpiprant act
    directly on the synthesis of eicosanoid mediators or their signaling molecules
    and receptors. Biosynthesis of endocannabinoids (2‐AG, AEA) interfere with eicosanoids
    metabolic pathways. 2‐AG—2‐Arachidonoyl‐glycerol (endocannabinoid); AEA—arachidonyl‐ethanolamide
    (endocannabinoid); COX—cyclooxygenase; Cyt—cytochrome; EET—epoxyeicosatrienoic
    acid; GC—glucocorticoids; HETE—hydroxyeicosatetraenoic acid; HPETE—hydroperoxyeicosatetraenoic
    acid; LOX—lipoxygenase; LTE4—leukotriene; LTRA—leukotriene receptor antagonists;
    LX—lipoxin; PLA—phospholipase; PG—prostaglandin; and TX—thromboxane
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ALOX5
  - ALOX15
  - CYSLTR1
  - COX1
  - PTGS1
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - APC
  - TFDP2
  - PTGDR2
  - COX2
  - PTGS2
  - MTCO2P12
  - GCLC
  - UGCG
  - CYP2B6
  - Alox5
  - Alox15
  - Cysltr1
  - Ptgs1
  - Pla2g2a
  - Pla2g5
  - Ptgs2
  - Ptgir
  - dv
  - CG42237
  - Gclc
  - Cyp4g1
  - Cyp4d1
  - Cyp4d2
  - Cyp4ae1
  - Cyp18a1
  - Cpr
  - Cyp4e3
  - Cyp6a2
  - Cyp9b1
  - Cyp9b2
  - Cyp4e2
  - Cyp6a9
  - Cyp6a20
  - Cyp6a21
  - Cyp6a8
  - Cyp9c1
  - Cyp4d8
  - Cyp12a4
  - Cyp4c3
  - Cyp4e1
  - Cyp4p1
  - Cyp6a22
---
